Main Day 2
9:00 am - 9:45 am Personalized Medicine and its Repercussions on Pharmacovigilance
10:00 am - 10:45 am Utilizing a Digital World for Adverse Drug Reactions (ADRs) to Increase your Quality Data Globally
11:15 am - 12:00 pm Strategies for Interpreting Regulations Globally
12:00 pm - 12:45 pm Spotlight: Asia as a Key Market for Pharmacovigilance
Rahul Khajuria
Director Global Drug Safety Systems & AnalyticsUnited Therapeutics Corporation
1:45 pm - 2:30 pm ROUNDTABLE DISCUSSIONS: Join conversations on the hottest topics in the industry by geography
2:30 pm - 3:15 pm Mapping out a Risk Management Plan (RMP)
3:45 pm - 4:30 pm Monitoring EudraVigilance: Your Role and Responsibilities
Agnieszka Majcher-Dann
Head of Safety Sciences and Policy, Consumer SegmentJohnson and Johnson